Analysis of new-onset seizures following use of COVID-19 vaccinations in children based on VAERS

References

• Lu L, Zhang Q, Xiao J, et al. COVID-19 vaccine take-up rate and safety in adults with epilepsy: data from a multicenter study in China. Epilepsia. 2022 Jan;63(1):244–251.
   PubMed Web of Science ®Google Scholar
• Fang X, Hu S, Han T, et al. Effect of inactivated COVID-19 vaccines on seizure frequency in patients with epilepsy: a multicenter, prospective study. Front Immunol. 2022;13:984789. doi: 10.3389/fimmu.2022.984789
   PubMed Web of Science ®Google Scholar
• Wang S, Lv J, He C, et al. COVID-19 vaccination hesitancy and safety among adult people with epilepsy in eastern China. Epilepsy Behav. 2023 Jan;138:108984. doi: 10.1016/j.yebeh.2022.108984
   PubMed Web of Science ®Google Scholar
• Avasarala J, McLouth CJ, Pettigrew LC, et al. VAERS-reported new-onset seizures following use of COVID-19 vaccinations as compared to influenza vaccinations. Br J Clin Pharmacol. 2022 Nov;88(11):4784–4788.
   PubMed Web of Science ®Google Scholar
• Pandit T, Pandit R, Goyal L. Uncommon side effects of COVID-19 vaccination in the pediatric population. Cureus. 2022 Oct;14(10):e30276. doi: 10.7759/cureus.30276
   PubMed Web of Science ®Google Scholar
• Zou D, Zhang R, Yu L, et al. Seizures associated with antibiotics: a real-world disproportionality analysis of FAERS database. Expert Opin Drug Saf. 2023 Jul;22(11):1143–1148.
   PubMed Web of Science ®Google Scholar
• Tieu C, Breder CD. A critical evaluation of safety signal analysis using algorithmic standardised MedDRA queries. Drug Saf. 2018 Dec;41(12):1375–1385. doi: 10.1007/s40264-018-0706-7
   PubMed Web of Science ®Google Scholar
• Ogura T, Shiraishi C. Parameter estimation of Weibull distribution for the number of days between drug administration and early onset adverse event. J Biopharm Stat. 2023 May 4;33(3):386–399. doi: 10.1080/10543406.2022.2154940
   PubMed Web of Science ®Google Scholar
• Komada F, Nakayama Y, Takara K. Analysis of time-to-onset and onset-pattern of interstitial lung disease after the administration of monoclonal antibody agents. Yakugaku Zasshi. 2018;138(12):1587–1594. doi: 10.1248/yakushi.18-00094
   PubMed Web of Science ®Google Scholar
• van Puijenbroek EP, Bate A, Leufkens HG, et al. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf. 2002 Jan;11(1):3–10.
   PubMed Web of Science ®Google Scholar
• Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001 Oct;10(6):483–486. doi: 10.1002/pds.677
   PubMed Web of Science ®Google Scholar
• Goss AL, Samudralwar RD, Das RR, et al. ANA investigates: neurological complications of COVID-19 vaccines. Ann Neurol. 2021 May;89(5):856–857.
   PubMed Web of Science ®Google Scholar
• Rosner CM, Genovese L, Tehrani BN, et al. Myocarditis temporally associated with COVID-19 vaccination. Circulation. 2021 Aug 10;144(6):502–505. doi: 10.1161/CIRCULATIONAHA.121.055891
   PubMed Web of Science ®Google Scholar
• Diaz GA, Parsons GT, Gering SK, et al. Myocarditis and pericarditis after vaccination for COVID-19. JAMA. 2021 Sep 28;326(12):1210–1212. doi: 10.1001/jama.2021.13443
   PubMed Web of Science ®Google Scholar
• Wangu Z, Swartz H, Doherty M. Multisystem inflammatory syndrome in children (MIS-C) possibly secondary to COVID-19 mRNA vaccination. BMJ Case Rep. 2022 Mar 30;15(3):e247176. doi: 10.1136/bcr-2021-247176
   PubMedGoogle Scholar
• Mendu SB, Singavarapu PR, Kota V, et al. Generalised tonic-clonic seizure in adolescents following COVID-19 vaccination: a case report on a mere Co-incidence. Cureus. 2023 Jun;15:(6):e40992.
   PubMed Web of Science ®Google Scholar
• Antoon JW, Hall M, Howard LM, et al. COVID-19 and acute neurologic complications in children. Pediatrics. 2022 Nov 1;150(5). doi: 10.1542/peds.2022-058167
   Web of Science ®Google Scholar
• Chen C, Fu F, Ding L, et al. Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: new insights from the vaccine adverse event reporting system. Front Immunol. 2022;13:938322. doi: 10.3389/fimmu.2022.938322
   PubMed Web of Science ®Google Scholar
• Hartnell NR, Wilson JP. Replication of the weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration. Pharmacotherapy. 2004 Jun;24(6):743–749. doi: 10.1592/phco.24.8.743.36068
   PubMed Web of Science ®Google Scholar
• Nunez I, Garcia-Grimshaw M, Castillo Valencia CY, et al. Seizures following COVID-19 vaccination in Mexico: a nationwide observational study. Epilepsia. 2022 Oct;63(10):e144–e149.
   PubMed Web of Science ®Google Scholar
• Kan Y, Nagai J, Uesawa Y. Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database. Sci Rep. 2021 May 5;11(1):9625. doi: 10.1038/s41598-021-88958-2
   PubMed Web of Science ®Google Scholar
• Okunaka M, Kano D, Matsui R, et al. Evaluation of the expression profile of irinotecan-induced diarrhea in patients with colorectal cancer. Pharmaceuticals (Basel). 2021 Apr 19;14(4):377. doi: 10.3390/ph14040377
   PubMedGoogle Scholar
• Varricchio F, Iskander J, Destefano F, et al. Understanding vaccine safety information from the vaccine adverse event reporting system. Pediatr Infect Dis J. 2004 Apr;23(4):287–294.
   PubMed Web of Science ®Google Scholar
• Shimabukuro TT, Nguyen M, Martin D, et al. Safety monitoring in the vaccine adverse event reporting system (VAERS). Vaccine. 2015 Aug 26;33(36):4398–4405. doi: 10.1016/j.vaccine.2015.07.035
   PubMed Web of Science ®Google Scholar